All technical guidance on COVID-19 Vaccines, treatment & tests COVID-19 Vaccines Vaccine equity COVID-19 vaccine delivery partnership COVID-19 Vaccines Advice ACT Accelerator & COVAX Diagnostics Clinical management The mRNA vaccine technology transfer hub ...
Considering the high morbidity and mortality from COVID-19 in patients with cancer, the benefits of vaccination are likely to far outweigh the risks of vaccine-related adverse events. Herein, we provide operational COVID-19 vaccine guidance for patients participating in oncology clinical trials. In...
Guidance for Individuals Vaccinated Outside of Ontario/Canada Residents of Ontario who received COVID-19 vaccine(s) outside of Ontario/Canada, should keep any documentation or records of these personal files. These out-of province records may be accepted by employers, educational institutions, health...
Information for Providers: Detailed guidance, recent updates and alerts/advisories all NYC providers should know. Vaccine Information for Providers: Recent news and updated guidance about COVID-19 vaccinations. Outpatient Therapeutics: Resources and information for providers so they can offer or refer pat...
Getting your COVID-19 vaccine helps protect you, your family, and your community. The Centers for Disease Control and Prevention (CDC) recommends everyone stay up to date with vaccines recommended for their age group. Speak with your doctor for individual guidance. ...
For patients with marrow failure from disease or therapy who are expected to have limited or no recovery, as well as for patients on long-term maintenance therapy, COVID-19 vaccination should be performed when the vaccine becomes available. ...
COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials Article 15 March 2021 The immuno-oncological challenge of COVID-19 Article 02 October 2020 Viral targets for vaccines against COVID-19 Article 18 December 2020 References...
The National Comprehensive Cancer Network (NCCN) this week published guidance on COVID-19 vaccination, treatment delays, and more for patients with cancer. “The most important thing is that people get whichever vaccine is offered to them as soon as they can,” said Steve Pergam, MD, MPH, ...
COVID-19的严重性和威胁 研究显示,COVID-19比季节性流感更严重、传染性更强(表1),它的基本再生数(R0)是后者的2倍。[8,15]季节性流感通常是自限性的,仅1.8%的病例需要住院。[20]但是,在中国超过一半的COVID-19报告病例出现肺炎并需要住院。[21,22]流感的病死率(Case fatality ratio, CFR)约为0.1%[...
根据目前的研究,我们可以得出阿斯利康COVID-19疫苗接种相关血栓形成与肝素诱导的血小板减少症(Heparin-induced thrombocytopenia,HIT)有共同的病理生理特征,被称为疫苗诱导的促血栓形成免疫性血小板减少症(Vaccine-induced prothrombotic immune thromb...